The Globe and Mail reports in its Thursday, March 7, edition that BMO Capital analyst Tim Casey reinstated coverage of Cineplex with a "market perform" rating and $12.50 share target, up from $11.50, following a balance sheet restructuring. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target Cineplex shares at $12.83. Mr. Casey says in a note: "Cineplex effectively extended maturity dates on high yield notes and convertible debentures, redeemed one third of outstanding convertible debentures and secured a covenant-lite credit facility. Q4 revenues and EBITDAaL missed expectations by 2 per cent and 22 per cent, respectively. Box office performance should improve through 2024 as the release schedule normalizes, with Q4 offering easy comps. The company is planning to open three LBE locations and one theatre in 2H/24." The Globe reported on April 25 and Feb. 9 that RBC Capital analyst Drew McReynolds rated Cineplex "outperform." It was then worth $8.83 and $7.90. The Globe reported on Sept. 28, Nov. 24 and Jan. 17 that National Bank Financial analyst Adam Shine continued to rank Cineplex "outperform." The shares could then be had for $8.87, $8.35 and $8.11.